# OnCo record paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014" ;
  schema:name "Overdiagnosis and overtreatment of prostate cancer"@en ;
  schema:alternateName "Loeb 2014 overdiagnosis review"@en, "prostate overdiagnosis 1.7 to 67 percent"@en ;
  schema:description "A review that gathered every way overdiagnosis in prostate cancer has been measured and found estimates from under two percent to two thirds, depending entirely on the method. The one figure everyone can agree on is that autopsy studies find prostate cancer in around a fifth to two fifths of men who died of something else."@en ;
  schema:url <https://onco.cc/key-papers/paper-loeb-overdiagnosis-overtreatment-prostate-eur-urol-2014/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.eururo.2013.12.062>, <https://pubmed.ncbi.nlm.nih.gov/24439788/> ;
  onco:tag "prostate-evidence" ;
  schema:sameAs <https://doi.org/10.1016/j.eururo.2013.12.062> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Loeb S, Bjurlin MA, Nicholson J, et al." ;
  onco:related <https://onco.cc/key-papers/paper-draisma-lead-time-overdiagnosis-psa-jnci-2009/>, <https://onco.cc/key-papers/paper-welch-albertsen-psa-era-diagnosis-treatment-jnci-2009/>, <https://onco.cc/key-papers/paper-klotz-active-surveillance-jco-2015/>, <https://onco.cc/ideas/idea-prev-gleason6-terminology-rct/>, <https://onco.cc/roadmaps/prostate-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/active-surveillance/> ;
  onco:terms <https://onco.cc/terms/overdiagnosis/>, <https://onco.cc/terms/screening/>, <https://onco.cc/terms/psa/>, <https://onco.cc/terms/gleason-grade-group/>, <https://onco.cc/terms/overtreatment/>, <https://onco.cc/terms/lead-time-bias/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-overdiagnosis/>, <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-patient-voice/> ;
  onco:journals <https://onco.cc/journals/european-urology/> .
